Density of antibiotic use and infectious complications in pediatric allogeneic hematopoietic cell transplantation
Details
Publication Year 2023-04,Volume 25,Issue #2,Page e14018
Journal Title
Transplant Infectious Disease
Publication Type
Research article
Abstract
BACKGROUND: Antibiotics, while an essential component of supportive care in allogeneic hematopoietic cell transplantation (allo-HCT), can have adverse effects and select for antibiotic resistance. Understanding of patterns of use will inform antimicrobial stewardship (AMS) interventions. METHODS: Retrospective, single-center cohort of children undergoing first allo-HCT (n = 125). Antibiotic prescription and infection data were included from the date conditioning was commenced until 30 days post allo-HCT. Antibiotic use was reported as length of therapy (LOT) (number of days a patient received an antibiotic) and days of therapy DOT (aggregating all antibiotics prescribed per day). Infections were classified as microbiologically documented infection (MDI) or clinically documented infections. RESULTS: At least one course of antibiotics was administered to 124 (99%) patients. The LOT was 636 per 1000 patient days and DOT was 959 per 1000 patient days. The median duration of cumulative antibiotic exposure per patient was 24 days (interquartile range [IQR] 20-30 days). There were 131 days of fever per 1000 patient days with patients febrile for a median of 4 days (IQR 1-7 days). Piperacillin-tazobactam was used for 116 (94%) of patients with an LOT of 532 per 1000 patient days. A total of 119 MDI episodes occurred in 74 (59%) patients, including blood stream infection in 30 (24%) and a proven/probable invasive fungal infection in 4 (3%). CONCLUSION: Pediatric HCT patients receive prolonged courses of broad-spectrum antibiotics relative to the frequency of fever and bacterial infections. This study has identified opportunities for AMS intervention to improve outcomes for our HCT patients.
Publisher
Wiley
Keywords
Humans; Child; Anti-Bacterial Agents/therapeutic use; Retrospective Studies; *Bacterial Infections/drug therapy/epidemiology/etiology; Fever/etiology; *Hematopoietic Stem Cell Transplantation/adverse effects; antibiotics; infections; microbiome; pediatrics; stem-cell transplantation
Department(s)
Infectious Diseases
PubMed ID
36748726
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-07-18 07:52:27
Last Modified: 2023-07-18 07:52:55

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙